Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$84,810
in 1 filing, $85K under 10b5-1 plans

Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Azoy Alexander −$85K Chief Accounting Officer sold 7% of stake

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-15 FALBERG KATHRYN E Director Gift −50,504 40,100
2023-06-15 FALBERG KATHRYN E Director Grant or award +6,800 46,900
2023-06-15 FALBERG KATHRYN E Director Grant or award · Stock Option (Right to Buy) +19,500 19,500
2023-06-07 Goeltz II Robert C. Chief Financial Officer Sale 10b5-1 −4,049 $20.04 $81K 59,392
2023-03-16 Jarrett Jennifer Chief Operating Officer Sale −8,729 $16.81 $147K 406,217
2023-01-27 Jarrett Jennifer Chief Operating Officer Sale −1,600 $23.52 $38K 414,946
2023-01-26 Jarrett Jennifer Chief Operating Officer Sale −300 $23.56 $7K 416,546
2023-01-23 Nuyten Dimitry SA Chief Medical Officer Grant or award +34,000 76,500
2023-01-23 Nuyten Dimitry SA Chief Medical Officer Grant or award · Stock Option (Right to Buy) +138,200 138,200
2023-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award +34,000 63,441
2023-01-23 Goeltz II Robert C. Chief Financial Officer Grant or award · Stock Option (right to buy) +138,200 138,200
2023-01-23 Tang Carolyn C. General Counsel Grant or award +34,000 97,539
2023-01-23 Tang Carolyn C. General Counsel Grant or award · Stock Option (right to buy) +138,200 138,200
2023-01-23 Jarrett Jennifer Chief Operating Officer Grant or award +45,800 416,846
2023-01-23 Jarrett Jennifer Chief Operating Officer Grant or award · Stock Option (right to buy) +185,900 185,900
2023-01-23 Jaen Juan C. President Grant or award +45,800 324,682
2023-01-23 Jaen Juan C. President Grant or award · Stock Option (right to buy) +185,900 185,900
2023-01-23 ROSEN TERRY J Chief Executive Officer Grant or award +105,700 469,123
2023-01-23 ROSEN TERRY J Chief Executive Officer Grant or award · Stock Option (right to buy) +429,000 429,000
2022-12-16 Goeltz II Robert C. Chief Financial Officer Sale −2,066 $30.66 $63K 11,953

Page 12 of 20 · 381 trades